找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Assisted Circulation 4; Felix Unger Book 1995 Springer-Verlag Berlin Heidelberg 1995 Artifical Hearts.Blood Circulation.Blood Pumps.circul

[復制鏈接]
樓主: Braggart
51#
發(fā)表于 2025-3-30 11:49:43 | 只看該作者
Colin Snook,Vitaly Savicks,Michael Butlerransplantation in a patient who could not be weaned from cardiopulmonary bypass [1]. Since then we have progressed, first using the Jarvik in 1987 [2], then the Hemopump in 1989, the Novacor LVAS in 1991, and implanting the first wearable Novacor in the spring of 1993 [3].
52#
發(fā)表于 2025-3-30 16:06:48 | 只看該作者
https://doi.org/10.1007/978-3-540-74792-5as on the basis of its efficacy. The mere fact that something is technically possible is no longer considered to be sufficient justification for funding continued research or providing patient care with costly treatment modalities. Expressed more directly, the days of preserving life at any cost appear to be over in this country.
53#
發(fā)表于 2025-3-30 19:17:10 | 只看該作者
54#
發(fā)表于 2025-3-30 23:00:48 | 只看該作者
55#
發(fā)表于 2025-3-31 01:40:22 | 只看該作者
56#
發(fā)表于 2025-3-31 07:32:57 | 只看該作者
Introduction: Clinical Realityrtner) or a moving diaphragm (Pierce, Unger, Frazier, Whalen) (Table 1). The driving source is either pneumatic or electromechanical via a tube through the skin. In the electromechanical driving mode, the incorporated devices need a compliance chamber. Furthermore, nonpulsatile blood pumps are also available.
57#
發(fā)表于 2025-3-31 11:37:00 | 只看該作者
Mechanical Circulatory Support at Henri Mondor Hospital: Indications for the Use of Different Deviceransplantation in a patient who could not be weaned from cardiopulmonary bypass [1]. Since then we have progressed, first using the Jarvik in 1987 [2], then the Hemopump in 1989, the Novacor LVAS in 1991, and implanting the first wearable Novacor in the spring of 1993 [3].
58#
發(fā)表于 2025-3-31 16:31:28 | 只看該作者
The Development of Low-cost Temporary and Permanent Circulatory Assist Devicesas on the basis of its efficacy. The mere fact that something is technically possible is no longer considered to be sufficient justification for funding continued research or providing patient care with costly treatment modalities. Expressed more directly, the days of preserving life at any cost appear to be over in this country.
59#
發(fā)表于 2025-3-31 17:54:36 | 只看該作者
Introductionpair of abdominoor abdominothoracic aneurysms. Different devices are available for clinical use, including impeller, aortic, and spindle-designed devices. Limitations are embolization and hemolysis from the pump.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 10:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
缙云县| 富平县| 繁峙县| 桃园县| 翼城县| 晋江市| 红安县| 芜湖县| 牙克石市| 潍坊市| 航空| 石景山区| 城市| 宜良县| 华阴市| 安远县| 木兰县| 巩留县| 杂多县| 乡城县| 普陀区| 疏勒县| 九寨沟县| 紫金县| 运城市| 平南县| 满城县| 城口县| 图们市| 新源县| 通化市| 都江堰市| 民丰县| 开化县| 策勒县| 博客| 庆安县| 永平县| 旬阳县| 鄯善县| 集贤县|